SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-15-006443
Filing Date
2015-10-07
Accepted
2015-10-07 18:31:13
Documents
3
Period of Report
2015-10-07

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 6429
2 EX-24 DOCUMENT attachment1.htm EX-24 3560
3 EX-99 DOCUMENT attachment2.htm EX-99 1172
  Complete submission text file 0000899243-15-006443.txt   13241
Mailing Address 650 GATEWAY BLVD. SUITE 125 SOUTH SAN FRANCISCO CA 94080
Business Address 650 GATEWAY BLVD. SUITE 125 SOUTH SAN FRANCISCO CA 94080 650.515.3185
CytomX Therapeutics, Inc. (Issuer) CIK: 0001501989 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2765 SAND HILL ROAD MENLO PARK CA 94025
Business Address 2765 SAND HILL ROAD MENLO PARK CA 94025 203-855-0400
Canaan IX L.P. (Reporting) CIK: 0001538676 (see all company filings)

State of Incorp.: E9 | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-37587 | Film No.: 151149807

Mailing Address 2765 SAND HILL ROAD MENLO PARK CA 94025
Business Address 2765 SAND HILL ROAD MENLO PARK CA 94025 6508548092
Canaan Partners IX LLC (Reporting) CIK: 0001654586 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-37587 | Film No.: 151149806